These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 8545823
1. Formation of paramagnetic chromium in liver of mice treated with dichromate (VI). Ueno S, Susa N, Furukawa Y, Sugiyama M. Toxicol Appl Pharmacol; 1995 Dec; 135(2):165-71. PubMed ID: 8545823 [Abstract] [Full Text] [Related]
2. EPR detection of paramagnetic chromium in liver of fish (Anguilla anguilla) treated with dichromate(VI) and associated oxidative stress responses-contribution to elucidation of toxicity mechanisms. Pacheco M, Santos MA, Pereira P, Martínez JI, Alonso PJ, Soares MJ, Lopes JC. Comp Biochem Physiol C Toxicol Pharmacol; 2013 Mar; 157(2):132-40. PubMed ID: 23142145 [Abstract] [Full Text] [Related]
10. Effects of vanadium(V) and/or chromium(III) on L-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney. Scibior A, Zaporowska H. J Toxicol Environ Health A; 2007 Apr 15; 70(8):696-704. PubMed ID: 17365624 [Abstract] [Full Text] [Related]
11. Effect of glutathione depletion on formation of paramagnetic chromium in Chinese hamster V-79 cells. Sugiyama M, Tsuzuki K. FEBS Lett; 1994 Mar 21; 341(2-3):273-6. PubMed ID: 8137952 [Abstract] [Full Text] [Related]
12. In vivo nephrotoxicity induced in mice by chromium(VI). Involvement of glutathione and chromium(V). Hojo Y, Satomi Y. Biol Trace Elem Res; 1991 Oct 21; 31(1):21-31. PubMed ID: 1724173 [Abstract] [Full Text] [Related]
13. Reductive activation of Cr(Vi) by nitric oxide synthase. Porter R, Jáchymová M, Martásek P, Kalyanaraman B, Vásquez-Vivar J. Chem Res Toxicol; 2005 May 21; 18(5):834-43. PubMed ID: 15892577 [Abstract] [Full Text] [Related]
14. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats. Standeven AM, Wetterhahn KE. Pharmacol Toxicol; 1991 Jun 21; 68(6):469-76. PubMed ID: 1891442 [Abstract] [Full Text] [Related]
15. Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water. Kerger BD, Paustenbach DJ, Corbett GE, Finley BL. Toxicol Appl Pharmacol; 1996 Nov 21; 141(1):145-58. PubMed ID: 8917687 [Abstract] [Full Text] [Related]
16. A novel mechanism for the enhancement of acetaminophen hepatotoxicity by phenobarbital. Douidar SM, Ahmed AE. J Pharmacol Exp Ther; 1987 Feb 21; 240(2):578-83. PubMed ID: 3806412 [Abstract] [Full Text] [Related]
17. Induction of lipid peroxidation in mice by hexavalent chromium and its relation to the toxicity. Susa N, Ueno S, Furukawa Y, Michiba N, Minoura S. Nihon Juigaku Zasshi; 1989 Dec 21; 51(6):1103-10. PubMed ID: 2601225 [Abstract] [Full Text] [Related]
18. Carcinogenic Cr(VI) and the nutritional supplement Cr(III) induce DNA deletions in yeast and mice. Kirpnick-Sobol Z, Reliene R, Schiestl RH. Cancer Res; 2006 Apr 01; 66(7):3480-4. PubMed ID: 16585171 [Abstract] [Full Text] [Related]
19. A new method to study glutathione adduct formation in periportal and pericentral regions of the liver lobule by micro-reflectance spectrophotometry. Harris C, Thurman RG. Mol Pharmacol; 1986 Jan 01; 29(1):88-96. PubMed ID: 3945230 [Abstract] [Full Text] [Related]
20. Biliary and gastrointestinal excretion of chromium after administration of Cr-III and Cr-VI in rats. Manzo L, Di Nucci A, Edel J, Gregotti C, Sabbioni E. Res Commun Chem Pathol Pharmacol; 1983 Oct 01; 42(1):113-25. PubMed ID: 6648036 [Abstract] [Full Text] [Related] Page: [Next] [New Search]